Search Results - Peter McLaughlin

Refine Results
  1. 1
    Meta–analyses of the association between <i>Chlamydia psittaci</i> and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics

    Meta–analyses of the association between <i>Chlamydia psittaci</i> and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics by Amina Husain, Dianna Roberts, Barbara Pro, Peter McLaughlin, Bita Esmaeli

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Cannabinoid CB1 receptor inverse agonists and neutral antagonists: Effects on food intake, food-reinforced behavior and food aversions

    Cannabinoid CB1 receptor inverse agonists and neutral antagonists: Effects on food intake, food-reinforced behavior and food aversions by John D. Salamone, Peter McLaughlin, Kelly S. Sink, Alexandros Makriyannis, Linda A. Parker

    Published 2007
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Stage I-II follicular lymphoma: Treatment results for 76 patients

    Stage I-II follicular lymphoma: Treatment results for 76 patients by Peter McLaughlin, Lillian M. Fuller, William S. Velasquez, Jane Sullivan‐Halley, James J. Butler, Fernando Cabanillas

    Published 1986
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Effect of alfalfa saponins on intestinal cholesterol absorption in rats

    Effect of alfalfa saponins on intestinal cholesterol absorption in rats by MR Malinow, Peter McLaughlin, Lynne Papworth, Clarence E. Stafford, GO Kohler, AL Livingston, PR Cheeke

    Published 1977
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Original article: A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the ‘tumor score’

    Original article: A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the ‘tumor score’ by José Rodríguez, Fernando Cabanillas, Peter McLaughlin, F Swan, Maria Alma Rodriguez, Frederick Hagemeister, Jorge Romaguera

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The association of specific “favorable” cytogenetic abnormalities with secondary leukemia

    The association of specific “favorable” cytogenetic abnormalities with secondary leukemia by Hagop M. Kantarjian, Michael J. Keating, Ronald S. Walters, Miloslav Beran, Peter McLaughlin, Kenneth B. McCredie, And Emil J Freireich

    Published 1986
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma

    Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma by Yasuhiro Oki, Barbara Pro, Luis Fayad, Jorge Romaguera, Felipe Samaniego, Fredrick Hagemeister, Sattva S. Neelapu, Peter McLaughlin, André Goy, Anas Younes

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data

    Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data by WS Velasquez, S Jagannath, S.L. Tucker, Fuller Lm, LB North, JR Redman, F Swan, FB Hagemeister, Peter McLaughlin, Fernando Cabanillas

    Published 1989
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas

    The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas by M-S Lee, MB Blick, Sen Pathak, JM Trujillo, JJ Butler, RL Katz, Peter McLaughlin, FB Hagemeister, WS Velasquez, A Goodacre

    Published 1987
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

    Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP) by WS Velasquez, Fernando Cabanillas, P. Salvador, Peter McLaughlin, Michael Fridrik, Søren M. Bentzen, Sundar Jagannath, FB Hagemeister, JR Redman, F Swan

    Published 1988
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Cholesterol and bile acid balance in Macaca fascicularis. Effects of alfalfa saponins.

    Cholesterol and bile acid balance in Macaca fascicularis. Effects of alfalfa saponins. by M.R. Malinow, W E Connor, Peter McLaughlin, Clarence E. Stafford, Don S. Lin, A. L. Livingston, G. O. Kohler, Wilbur P. McNulty

    Published 1981
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin’s lymphoma

    Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin’s lymphoma by Chitra Hosing, Rima M. Saliba, Peter McLaughlin, Börje S. Andersson, Maria Alma Rodriguez, Laura M. Fayad, Fernando Cabanillas, Richard E. Champlin, Issa F. Khouri

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte

    Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte by Fernando Cabanillas, Sen Pathak, José M. Trujillo, Grace Grant, Ann Cork, FB Hagemeister, WS Velasquez, Peter McLaughlin, J R Redman, Ruth L. Katz

    Published 1988
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha

    Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha by Peter McLaughlin, Elihu H. Estey, Armand B. Glassman, Jorge Romaguera, Felipe Samaniego, Ana Ayala, Kimberly Hayes, Anne Marie Maddox, H. Alejandro Preti, Fredrick B. Hagemeister

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma

    Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma by Neil L. Berinstein, A.J. Grillo-López, Christine A. White, Isabelle Bence‐Bruckler, David G. Maloney, M. S. Czuczman, D. Green, J. Rosenberg, Peter McLaughlin, Diying Shen

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    A pilot study of rituximab in patients with recurrent, classic Hodgkin disease

    A pilot study of rituximab in patients with recurrent, classic Hodgkin disease by Anas Younes, Jorge Romaguera, Frederick Hagemeister, Peter McLaughlin, Maria Alma Rodriguez, Paolo Fiumara, André Goy, Sima Jeha, John T. Manning, Dan Jones, Lynne V. Abruzzo, L. Jeffrey Medeiros

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

    The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats by Kelly S. Sink, Peter McLaughlin, Jodi Wood, C. Brown, Pusheng Fan, Kiran Vemuri, Yan Pang, Teresa Olzewska, Ganesh A. Thakur, A. Makriyannis, Linda A. Parker, John D. Salamone

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma by Apostolia M. Tsimberidou, Sijin Wen, Peter McLaughlin, Susan O’Brien, William G. Wierda, Susan Lerner, Sara S. Strom, Emil J. Freireich, L. Jeffrey Medeiros, Hagop M. Kantarjian, Michael J. Keating

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma

    Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma by Bita Esmaeli, Peter McLaughlin, Barbara Pro, Felipe Samaniego, Isis Gayed, Fredrick B. Hagemeister, Jorge Romaguera, Fernando Cabanillas, Sattva S. Neelapu, R. Banay, Luis Fayad, M. Wayne Saville, Larry W. Kwak

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas

    The Clinical Significance of Molecular Response in Indolent Follicular Lymphomas by Armando López‐Guillermo, Fernando Cabanillas, Peter McLaughlin, Terry Smith, Fredrick B. Hagemeister, M. A. Rodriguez, Jorge Romaguera, Anas Younes, Andreas H. Sarris, H. Alejandro Preti, William Pugh, Ming-Seng Lee

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: